In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Winston & Strawn
- O'Hagan Meyer
- Motley Rice
- Hilliard & Shadowen
- Smith Segura Raphael & Leger
- Durrette Arkema
- Girard Sharp
- Grabar Law
- Zelle LLP
- Boies Schiller
- Kaufman & Canoles
- Garwin Gerstein
- Ventker Henderson
- Wexler Boley
- Heins Mills
- DurretteCrump
- Duncan & Allen
- Fisher & Phillips
- Miller Shah LLP
- Wolcott Rivers
- Faruqi & Faruqi
- Cohen Milstein
- Glasser & Glasser
- Lockridge Grindal
- Willcox & Savage
- Hagens Berman
- Marcus & Shapira
- Hangley Aronchick
- BoiesBattin
- McGuireWoods
- The Office of Craig C. Reilly
- Nussbaum Law Group
- Crenshaw Ware
- Kessler Topaz
- Katten Muchin
- Williams & Connolly
- Joseph Saveri Law Firm
- Hartley LLP
- Furniss Davis
- Gibson Dunn
- Radice Law Firm
- Morgan Lewis
- Taus Cebulash
- Kirkland & Ellis
- Wilson Sonsini
- Goldman Ismail
- Crowell & Moring
- DLA Piper
- Sperling Kenny
- Woods Rogers
- Berger Montague
- McDermott Will & Emery
- Gustafson Gluek
- Glancy Prongay
- Labaton Keller
- White & Case
Companies
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Merck & Co. Inc.
- Fraternal Order of Police
- The Kroger Co.
- Health Net Inc.
- H.D. Smith LLC
- Mutual Drug
- Humana Inc.
- Albertsons Cos. Inc.
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- United Food & Commercial Workers International Union
- Cardinal Health Inc.
- CVS Health Corp.
- McKesson Corp.
- Glenmark Pharmaceuticals Ltd.
- Zydus Pharmaceuticals Inc.
- Cencora Inc.
- Centene Corp.
- Giant Eagle Inc.
- H‑E‑B LP
- Rite Aid Corp.
- Wegmans Food Markets Inc.
Sectors & Industries:
-
November 02, 2018
Zetia MDL Buyers Maintain Merck's Generic Deal Was Illegal
A Virginia federal court shouldn't throw out multidistrict litigation accusing Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. of manipulating the generic drug market to keep prices of the cholesterol medication Zetia high, buyers of the drug urged, claiming they can prove antitrust violations.
-
October 12, 2018
Merck, Glenmark Tear Apart Zetia Pay-For-Delay MDL Claims
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. have asked a Virginia federal court to throw out three complaints in multidistrict litigation accusing them of entering into an illegal reverse-payment deal to keep a generic version of the cholesterol drug Zetia off the market.
-
July 30, 2018
Lawyers Compete To Represent Zetia Buyers In Antitrust Case
More than a half-dozen law firms representing buyers of the cholesterol drug Zetia launched competing bids Friday to act as interim counsel for end payors for the drug in an antitrust MDL accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.
-
July 03, 2018
Direct Drug Purchasers Aim For Consolidation In Zetia MDL
A putative class of direct purchasers of the cholesterol drug Zetia asked a Virginia federal judge on Monday to consolidate their antitrust claims accusing Merck & Co. of orchestrating a pay-for-delay scheme to keep a generic version of the drug off the market.